New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Effect of noradrenergic drugs explored in Alzheimer’s disease
Jul 29, 2022
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition and apathy.
Exercise, chores, social visits linked to lower dementia risk
Jul 28, 2022
Comparable results were seen for dementia, vascular dementia, Alzheimer’s disease, and in analyses stratified by dementia polygenic risk score.
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.
Medicare spending spikes for dementia diagnoses in seniors
Jun 13, 2022
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Vestibular system impairment tied to fall risk in Alzheimer’s patients
Mar 18, 2022
A significant association was seen between semicircular canal function with lower likelihood of falls in adjusted analysis.
AAN: Higher fitness level tied to lower Alzheimer’s disease risk
Feb 28, 2022
A graded association was seen between levels of cardiorespiratory fitness and the incidence of Alzheimer’s disease and related disorders.